1. Home
  2. ME vs BHST Comparison

ME vs BHST Comparison

Compare ME & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ME
  • BHST
  • Stock Information
  • Founded
  • ME 2006
  • BHST N/A
  • Country
  • ME United States
  • BHST Canada
  • Employees
  • ME N/A
  • BHST N/A
  • Industry
  • ME Precision Instruments
  • BHST
  • Sector
  • ME Health Care
  • BHST
  • Exchange
  • ME Nasdaq
  • BHST Nasdaq
  • Market Cap
  • ME 113.9M
  • BHST 104.0M
  • IPO Year
  • ME N/A
  • BHST N/A
  • Fundamental
  • Price
  • ME $3.11
  • BHST $6.22
  • Analyst Decision
  • ME Hold
  • BHST
  • Analyst Count
  • ME 1
  • BHST 0
  • Target Price
  • ME $9.40
  • BHST N/A
  • AVG Volume (30 Days)
  • ME 453.1K
  • BHST N/A
  • Earning Date
  • ME 11-12-2024
  • BHST N/A
  • Dividend Yield
  • ME N/A
  • BHST N/A
  • EPS Growth
  • ME N/A
  • BHST N/A
  • EPS
  • ME N/A
  • BHST N/A
  • Revenue
  • ME $193,260,000.00
  • BHST N/A
  • Revenue This Year
  • ME $21.93
  • BHST N/A
  • Revenue Next Year
  • ME $17.31
  • BHST N/A
  • P/E Ratio
  • ME N/A
  • BHST N/A
  • Revenue Growth
  • ME N/A
  • BHST N/A
  • 52 Week Low
  • ME $2.66
  • BHST N/A
  • 52 Week High
  • ME $20.40
  • BHST N/A
  • Technical
  • Relative Strength Index (RSI)
  • ME 30.62
  • BHST N/A
  • Support Level
  • ME $2.66
  • BHST N/A
  • Resistance Level
  • ME $3.58
  • BHST N/A
  • Average True Range (ATR)
  • ME 0.45
  • BHST 0.00
  • MACD
  • ME -0.08
  • BHST 0.00
  • Stochastic Oscillator
  • ME 16.90
  • BHST 0.00

About ME 23andMe Holding Co.

23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.

Share on Social Networks: